Who owns JASPER THERAPEUTICS INC?
- CUSIP Number: 471871103
Tip: Access positions for across all investors
Analyze quarterly positions in Jasper Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Jasper Therapeutics stock
Who bought or sold JASPER THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Velan Capital Investment Management | 11M | $6.8M | 0% | Sep 2023 |
|
Soleus Capital Management | 9.9M | $7.8M | 19% | Dec 2023 |
|
Carlyle | 8.8M | $6.7M | 0% | Dec 2023 |
|
Qiming U.S. Ventures Management | 8.5M | $6.7M | 0% | Dec 2023 |
|
Octagon Capital Advisors | 4.5M | $3.5M | 0% | Dec 2023 |
|
Vanguard Group | 4.1M | $3.2M | 8% | Dec 2023 |
|
Opaleye Management | 4.0M | $3.1M | 100% | Dec 2023 |
|
Kingdon Capital Management | 3.5M | $2.8M | 16% | Dec 2023 |
|
Bank of America Corporation | 3.2M | $2.5M | 0% | Dec 2023 |
|
Ally Bridge Group | 3.1M | $2.2M | 25% | Sep 2023 |
|
Woodline Partners | 3.0M | $2.1M | 0% | Sep 2023 |
|
Altium Capital Management | 2.9M | $2.0M | 0% | Sep 2023 |
|
Nantahala Capital Management | 2.2M | $1.8M | -7% | Dec 2023 |
|
Saturn V Capital Management | 1.4M | $971k | 100% | Sep 2023 |
|
BlackRock | 1.3M | $925k | -1% | Sep 2023 |
|
Geode Capital Management | 905k | $633k | -6% | Sep 2023 |
|
Landscape Capital Management | 789k | $623k | 100% | Dec 2023 |
|
Morgan Stanley | 781k | $547k | 143% | Sep 2023 |
|
Sphera Funds Management | 713k | $5.6M | -87% | Dec 2023 |
|
Mariner Wealth Advisors | 591k | $466k | -10% | Dec 2023 |
|
Bank Of Montreal | 348k | $279k | 100% | Dec 2023 |
|
Renaissance Technologies | 310k | $217k | 434% | Sep 2023 |
|
Monaco Asset Management SAM | 250k | $197k | 100% | Dec 2023 |
|
Boothbay Fund Management | 233k | $163k | 0% | Sep 2023 |
|
Citadel Advisors | 230k | $182k | 56% | Dec 2023 |
|
State Street Corporation | 230k | $161k | 16% | Sep 2023 |
|
Cowen And Company | 200k | $158k | 0% | Dec 2023 |
|
Northern Trust | 155k | $108k | 0% | Sep 2023 |
|
Millennium Management | 130k | $103k | 108% | Dec 2023 |
|
Forefront Analytics | 111k | $78k | 60% | Sep 2023 |
|
Summit Trail Advisors | 65k | $51k | 0% | Dec 2023 |
|
Ieq Capital | 55k | $43k | 100% | Dec 2023 |
|
Two Sigma Investments | 54k | $43k | -18% | Dec 2023 |
|
Bank of New York Mellon | 44k | $34k | 0% | Dec 2023 |
|
Charles Schwab Investment Management | 37k | $29k | 0% | Dec 2023 |
|
Gries Financial | 24k | $17k | 0% | Sep 2023 |
|
Lazard Asset Management | 12k | $0 | 3% | Dec 2023 |
|
Jane Street | 11k | $8.8k | 100% | Dec 2023 |
|
Cutler | 1.2k | $0 | 0% | Dec 2023 |
|
Wells Fargo & Company | 609.00 | $480.988200 | -19% | Dec 2023 |
|
Royal Bank of Canada | 257.00 | $0 | 100% | Dec 2023 |
|
FMR | 100.00 | $70.000000 | 100% | Sep 2023 |
|
Simplex Trading | 26.00 | $0 | 100% | Dec 2023 |
|
Group One Trading | 1.00 | $1.000000 | -100% | Sep 2023 |
|
Who sold out of Jasper Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
BVF | Sep 2023 | 9.9M | $6.9M |
Franklin Resources | Sep 2023 | 4.5M | $3.2M |
Ikarian Capital | Sep 2023 | 1.1M | $788k |
Scoggin | Sep 2023 | 508k | $356k |
Silverarc Capital Management | Jun 2023 | 500k | $685k |
Leucadia National Corporation | Jun 2023 | 490k | $671k |
Affinity Asset Advisors | Jun 2023 | 477k | $653k |
Fernwood Investment Management | Sep 2023 | 455k | $318k |
Susquehanna International | Jun 2023 | 63k | $86k |
One68 Global Capital | Jun 2023 | 20k | $27k |
XTX Topco | Jun 2023 | 11k | $16k |
Tower Research Capital | Jun 2023 | 9.4k | $13k |